Boris V Stanzel
Overview
Explore the profile of Boris V Stanzel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
615
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rudolph C, Boden K, Szurman P, Stanzel B
Ophthalmologie
. 2024 Apr;
121(7):575-578.
PMID: 38687381
No abstract available.
2.
Al-Nawaiseh S, Krotz C, Rickmann A, Strack C, Germann A, von Briesen H, et al.
Graefes Arch Clin Exp Ophthalmol
. 2023 Mar;
261(8):2265-2280.
PMID: 36976356
Purpose: We aimed to establish a rabbit model with retinal atrophy induced by an iatrogenic retinal pigment epithelium (RPE) removal, for future testing of the efficacy and safety of cell...
3.
Tan S, Steel D, Stanzel B, Bedersdorfer M, Szurman P, Saidkasimova S, et al.
Eye (Lond)
. 2022 Jul;
37(8):1553-1557.
PMID: 35864162
Objectives: To investigate the safety and effectiveness of pre-emptive vitrectomy in eyes with severe non-fibrotic proliferative diabetic retinopathy. Methods: A multi-centre, retrospective, observational study. Pre-emptive vitrectomy was performed in non-fibrotic...
4.
Koster C, van den Hurk K, Ten Brink J, Lewallen C, Stanzel B, Bharti K, et al.
Int J Mol Sci
. 2022 Mar;
23(6).
PMID: 35328338
Purpose: The lack of suitable animal models for (dry) age-related macular degeneration (AMD) has hampered therapeutic research into the disease, so far. In this study, pigmented rats and mice were...
5.
Liu Z, Ilmarinen T, Tan G, Hongisto H, Wong E, Tsai A, et al.
Stem Cell Res Ther
. 2021 Jul;
12(1):423.
PMID: 34315534
Background: Human pluripotent stem cells (hPSCs) provide a promising cell source for retinal cell replacement therapy but often lack standardized cell production and live-cell shipment logistics as well as rigorous...
6.
Seah I, Liu Z, Wong D, Wong W, Holder G, Barathi V, et al.
J Vis Exp
. 2021 Jun;
(172).
PMID: 34180899
Retinal pigment epithelial (RPE) transplantation holds great promise for the treatment of inherited and acquired retinal degenerative diseases. These conditions include retinitis pigmentosa (RP) and advanced forms of age-related macular...
7.
Szurman P, Wakili P, Stanzel B, Siegel R, Boden K, Rickmann A
Graefes Arch Clin Exp Ophthalmol
. 2021 Jun;
259(7):1781-1790.
PMID: 34076741
Purpose: This study aims to analyze the success rate and functional outcome after revision surgery of persistent idiopathic full-thickness macular holes in a large patient cohort and to identify the...
8.
El Mourad S, Al-Nawaiseh S, Szurman P, Stanzel B
Ophthalmologe
. 2021 Feb;
119(2):190-194.
PMID: 33595688
No abstract available.
9.
Tan G, Liu Z, Ilmarinen T, Barathi V, Chee C, Lingam G, et al.
Transl Vis Sci Technol
. 2021 Jan;
10(1):10.
PMID: 33510949
Purpose: Delivery of Advanced Therapy Medicinal Products to the submacular space is increasingly evolving into a therapeutic modality. Cell replacement for age-related macular degeneration (AMD) and gene therapy for RPE65...
10.
Liu Z, Parikh B, Tan Q, Wong D, Ong K, Yu W, et al.
Stem Cell Reports
. 2021 Jan;
16(2):237-251.
PMID: 33450191
Recent trials of retinal pigment epithelium (RPE) transplantation for the treatment of disorders such as age-related macular degeneration have been promising. However, limitations of existing strategies include the uncertain survival...